Press Release

Barcelona, Spain. Salvador Aznar Benitah, ONA scientific co-founder speaks about entrepreneurship and the new role for scientists.

Salvador Aznar Benitah, Group Leader del Stem Cells and Cancer Laboratory del IRB Barcelona y cofundador de la spin-off Ona Therapeutics. Investigador ICREA, Aznar llegó al IRB Barcelona hace seis años. Su trabajo ha estado focalizado en entender cómo se regeneran los tejidos humanos. Cómo las células madre lidian con el daño; con heridas, quemaduras o infecciones.

Salvador Aznar, investigador del IRB y confundador de Ona Therapeutics.

“El problema es que es en estas células, las más longevas del tejido, donde se originan los tumores. Estudiamos qué mecanismos las convierten en algo incontrolable que no sigue ninguna pauta. Lo que empieza como un tumor en la piel invade otros tejidos en pulmones, hígado o huesos y deriva en un problema ante el que hay poco que hacer. Es la metástasis la que mata a los pacientes en el 90 por ciento de los casos”, detalla el investigador.

Read the full interview here (in Spanish): https://www.innovaspain.com/anuario2019/irb-barcelona/

Ona Therapeutics
Privacy Overview
ONA THERAPEUTICS, SL obtains personal data through the contact forms of the web, from those who submit any questions, requests and / or comments.
In accordance with current regulations on Data Protection, specifically, Regulation (EU) 2016/679 of the European Parliament and of the Council, of April 27, 2016, personal data provided to ONA THERAPEUTICS, SL through this web portal will become part of its information systems that comply with the security measures required in order to guarantee the confidentiality, integrity, security and information retrieval.
The purposes for which these data are collected are those of being able to respond to your queries regarding the services we offer. In addition, of the timely response to your queries, we may, if you authorize us to do so, send you information electronically.
Your data will be kept for the period that you are registered to receive the requested information, being your revocable consent, it may be withdrawn at any time through the link that accompanies each shipment to communicate your WITHDRAWN or through an email to the address info@ona-therapeutics.com. From that moment, you will no longer receive any communication from us.
We will not proceed with the communication or transfer of your data, in any case, unless a public body requires it in accordance with the Law and those in charge of treatment that provide services related to our information systems.
You have the right to obtain confirmation about whether we are treating your personal data, therefore, you have the right to access your personal data (Right of Access), you have the right to rectify inaccurate data (Right of Rectification) or to request its deletion (Right to deletion) when the data is no longer necessary, you have the right to exercise your opposition to the processing of data (Right of opposition), to exercise your right to the limitation of the processing, as well as you will have the right to the portability of your data, if it is the case. All this by writing to our access addresses in Calle Baldiri Reixach 10, Barcelona, ​​Spain or via email info@ona-therapeutics.com in accordance with the procedure of articles 15 to 23 of Regulation (EU) 2016 / 679 of the European Parliament and of the Council, of April 27, 2016.
ONA THERAPEUTICS, SL, declares to have implemented the necessary technical and organizational security measures that guarantee the security of the data and prevent its alteration, loss, treatment or unauthorized access, taking into account the state of the technology, the nature of the stored data and the risks to which they are exposed, already come from human action or from the physical or natural environment.
To protect the privacy of the USERS, it is prohibited to send any information regarding their ideology, religion, beliefs, racial origin, health, and sexual life through our forms.
Likewise, we inform you that, under no circumstances will automated individual decisions or profiling be made.